Abstract 321: Lymphatic derived HDL Is an Effective Donor for the Trans-Intestinal Cholesterol Efflux Pathway That Is Impaired During Insulin Resistance

2015 ◽  
Vol 35 (suppl_1) ◽  
Author(s):  
Rabban Mangat ◽  
Faye Borthwick ◽  
Donna F Vine ◽  
Spencer D Proctor

Introduction: Emerging evidence shows that the proximal small intestine secretes cholesterol into the intestinal lumen via the trans-intestinal cholesterol excretion (TICE) pathway. It is thought TICE can contribute up to 30-40% of fecal neutral sterol excretion. Plasma apoB containing lipoproteins are known to donate cholesterol to the TICE pathway whilst conflicting evidence exists on the role for plasma HDL. Due to the anatomical proximity of lymphatic vessels to the basolateral membrane of enterocytes, it may serve as a candidate donor to TICE, but to date this has not been tested. Objective: To determine if HDL derived from mesenteric lymph can act as cholesterol donor for TICE in JCR:LA cp rats as a model of insulin resistance (IR). Methods: Mesenteric lymph was collected following intralipid infusion via lymphatic cannulation from control rats. Lymph HDL was isolated using ultra-density centrifugation and labeled with H3 cholesterol. Jejunal explants were obtained from control and IR rats (as a model of reduced TICE) fed chow or a high fat/cholesterol diet. TICE was measured with Ussing Chambers as appearance of H3-cholesterol labeled lymph HDL using micelles as acceptors. Results: Relative to free cholesterol [FC; used as marker of non-specific lipid permeability], lymph derived HDL TICE was 77% higher in control tissue (n=5, p<0.05) under chow fed conditions, suggestive of an effective donor for TICE. Lymph HDL TICE was also reduced (89%, p<0.05) in IR rats compared to control. Furthermore SR-B1 mRNA was reduced (-65%) in enterocytes from IR rats compared to control, and may explain reduced TICE by lymph HDL in IR. Under conditions of high fat/cholesterol fed diet, TICE from FC [and mannitol as a marker of paracellular transport] was increased in both control and IR rats, suggesting an elevated non-specific permeability of lipids by the basolateral membrane. Conclusions: Consistent with evidence that the lymphatics have a role in reverse cholesterol transport, this data supports that lymph HDL is an effective donor for TICE possibly by the SR-B1 pathway. While we have shown that the lymph HDL TICE pathway may be impaired during insulin resistance, a high fat/cholesterol diet may exacerbate lipid permeability via non-specific efflux pathways.

Endocrinology ◽  
2014 ◽  
Vol 155 (12) ◽  
pp. 4697-4705 ◽  
Author(s):  
Anisha A. Gupte ◽  
Omaima M. Sabek ◽  
Daniel Fraga ◽  
Laurie J. Minze ◽  
Satoru K. Nishimoto ◽  
...  

Nonalcoholic fatty liver disease, particularly its more aggressive form, nonalcoholic steatohepatitis (NASH), is associated with hepatic insulin resistance. Osteocalcin, a protein secreted by osteoblast cells in bone, has recently emerged as an important metabolic regulator with insulin-sensitizing properties. In humans, osteocalcin levels are inversely associated with liver disease. We thus hypothesized that osteocalcin may attenuate NASH and examined the effects of osteocalcin treatment in middle-aged (12-mo-old) male Ldlr−/− mice, which were fed a Western-style high-fat, high-cholesterol diet for 12 weeks to induce metabolic syndrome and NASH. Mice were treated with osteocalcin (4.5 ng/h) or vehicle for the diet duration. Osteocalcin treatment not only protected against Western-style high-fat, high-cholesterol diet-induced insulin resistance but substantially reduced multiple NASH components, including steatosis, ballooning degeneration, and fibrosis, with an overall reduction in nonalcoholic fatty liver disease activity scores. Further, osteocalcin robustly reduced expression of proinflammatory and profibrotic genes (Cd68, Mcp1, Spp1, and Col1a2) in liver and suppressed inflammatory gene expression in white adipose tissue. In conclusion, these results suggest osteocalcin inhibits NASH development by targeting inflammatory and fibrotic processes.


2013 ◽  
Vol 305 (5) ◽  
pp. E573-E584 ◽  
Author(s):  
Marc-André Laplante ◽  
Alexandre Charbonneau ◽  
Rita Kohen Avramoglu ◽  
Patricia Pelletier ◽  
Xiangping Fang ◽  
...  

Cholesterol and triglyceride-rich Western diets are typically associated with an increased occurrence of type 2 diabetes and vascular diseases. This study aimed to assess the relative impact of dietary cholesterol and triglycerides on glucose tolerance, insulin sensitivity, atherosclerotic plaque formation, and endothelial function. C57BL6 wild-type (C57) mice were compared with atherosclerotic LDLr−/− ApoB100/100 (LRKOB100) and atherosclerotic/diabetic IGF-II × LDLr−/− ApoB100/100 (LRKOB100/IGF) mice. Each group was fed either a standard chow diet, a 0.2% cholesterol diet, a high-fat diet (HFD), or a high-fat 0.2% cholesterol diet for 6 mo. The triglyceride-rich HFD increased body weight, glucose intolerance, and insulin resistance but did not alter endothelial function or atherosclerotic plaque formation. Dietary cholesterol, however, increased plaque formation in LRKOB100 and LRKOB100/IGF animals and decreased endothelial function regardless of genotype. However, cholesterol was not associated with an increase of insulin resistance in LRKOB100 and LRKOB100/IGF mice and, unexpectedly, was even found to reduce the insulin-resistant effect of dietary triglycerides in these animals. Our data indicate that dietary triglycerides and cholesterol have distinct metabolic and vascular effects in obese atherogenic mouse models resulting in dissociation between the impairment of glucose homeostasis and the development of atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document